Feasibility and Acceptability Study of Pulihkan Luka: a website-based psychoeducational program for trauma-related symptoms

Feasibility and Acceptability Study of Pulihkan Luka: a website-based psychoeducational program for trauma-related symptoms in an Indonesian undergraduate student population

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230721001

Enrollment

130

Registered

2023-07-21

Start date

2023-11-21

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Help-seeking intention for mental health complaints, psychological well-being, mental health literacy, and symptoms of PTSD, depression, anxiety, and insomnia in Indonesian undergraduate students population with trauma-related experience and probable trauma-related mental health disorders. Help-Seeking Behavior, Psychological Well Being, Post-Traumatic Stress Disorder, Depression, Anxiety, Insomnia,

Interventions

The Pulihkan Luka (PL) Program involves four to seven 30-minute website-based personalized psychoeducation modules that enhance participants understanding of how trauma exposure can affect physical an

Experimental Behavioral,No Intervention Other

Pulihkan Luka (PL) Program,Enhanced Usual Care (EUC)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Enrollment as an undergraduate student living in Indonesia 2. Having experienced at least one traumatic event according to the Life Event Checklist for DSM-5 (LEC-5) 3. Endorsing items of the Global Psychotrauma Screen (GPS) indicating at least one probable mental disorder related to the traumatic event (PTSD, Complex PTSD, anxiety, depression, insomnia, and self-harm) 4. Proficient in the Indonesian language 5. Having access to internet broadband

Exclusion criteria

Exclusion criteria: Currently receiving psychological or medical treatment (counseling/psychotherapy/psychotropic medications) for mental health problems.

Design outcomes

Primary

Measure	Time frame
Feasibility (intervention uptake, intervention adherence, and feasibility) One week after the intervention phase (post-intervention asessment/T2) percentage of module attendance, MT4C-in Care feasibility survey score,Acceptability (Intention to use the PL Program, and User satisfaction) One week after the intervention phase (post-intervention asessment/T2) Internet-based Interventions Acceptability Questionnaire-Indonesia (IIAQ-ID) score, SIN-E-Stress user satisfaction survey score	—

Measure

Time frame

Feasibility (intervention uptake, intervention adherence, and feasibility) One week after the intervention phase (post-intervention asessment/T2) percentage of module attendance, MT4C-in Care feasibility survey score,Acceptability (Intention to use the PL Program, and User satisfaction) One week after the intervention phase (post-intervention asessment/T2) Internet-based Interventions Acceptability Questionnaire-Indonesia (IIAQ-ID) score, SIN-E-Stress user satisfaction survey score

—

Secondary

Measure	Time frame
Help-seeking intention Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The General Help-Seeking Questionnaire (GHSQ) score,Psychological Well-being Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The World Health Organization-Five Well Being Index (WHO-5) score ,PTSD symptoms Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The PTSD Checklist for DSM-5 (PCL-5) score,Depression symptoms Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The Patient Health Questionnaire (PHQ-9) score,Anxiety symptoms Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The General Anxiety Disorder (GAD-7) score,Insomnia symptoms Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The Insomnia Severity Index (ISI) score,Mental health literacy Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) Mental health literacy questionnaire score	—

Measure

Time frame

Help-seeking intention Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The General Help-Seeking Questionnaire (GHSQ) score,Psychological Well-being Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The World Health Organization-Five Well Being Index (WHO-5) score ,PTSD symptoms Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The PTSD Checklist for DSM-5 (PCL-5) score,Depression symptoms Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The Patient Health Questionnaire (PHQ-9) score,Anxiety symptoms Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The General Anxiety Disorder (GAD-7) score,Insomnia symptoms Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) The Insomnia Severity Index (ISI) score,Mental health literacy Baseline (T1), 1 week after the intervention phase (post-intervention asessment/T2), approximately 90 days and 180 days after the intervention phase (3-month and 6-month follow-up assessment/T3 & T4) Mental health literacy questionnaire score

—

Countries

Netherlands

Contacts

Public ContactIndira Primasari

Amsterdam UMC

i.d.primasari@amsterdamumc.nl3120 891360

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026